ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ChiCTR
Last refreshed on:	18 April 2017
Main ID:	ChiCTR-TRC-11001691
Date of registration:	2011-10-13
Prospective Registration:	No
Primary sponsor:	Peking University People's Hospital
Public title:	Clinical trial of megakaryocyte progenitor generated from cord blood to treat thrombocytopenia after chemotherapy or radiotherapy of hematolgical maligance
Scientific title:	Treatment of hematopoietic injury of hematolgical maligance after chemotherapy or radiotherapy
Date of first enrolment:	2011-06-14
Target sample size:	1:122;2:122;
Recruitment status:	Completed
URL:	http://www.chictr.org.cn/showproj.aspx?proj=7854
Study type:	Interventional study
Study design:	Randomized parallel controlled trial
Phase:	I (Phase I study)

Countries of recruitment

Contacts

Name:	Honghu Zhu
Address:	11 Xizhimen South Street, Beijing
Telephone:	+86 13671232272
Email:	zhuhhdoc@163.com
Affiliation:	Peking University People's Hospital

Name:	Xiaojun Huang
Address:	11 Xizhimen South Street, Beijing
Telephone:	+86 13701389625
Email:	xjhrm@medmail.com.cn
Affiliation:

Key inclusion & exclusion criteria

Inclusion criteria: 1. age: 18-70 years old;
2. male or female;
3. cin first complete remission;
4. prepare to receive two courses of the same consoldation chemotherapy;
5. predictive survival over three months;
6. PS score(ECOG) 0 or 1.
Exclusion criteria: 1. thrombocytopenia unrelate to chemotherapy or radiotherapy of hematolgical magligance;
2. severe injury of organ function;
3. prognacy or in the period of breast-feed;
4. not assign informed consent.

Age minimum: 18
Age maximum: 70
Gender: Both

Health Condition(s) or Problem(s) studied

hematolgical maligance

Intervention(s)

1:transfusion of megakaryocyte progenitor generated;2:basal treatment;

Primary Outcome(s)

recovery time of platele;

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

National High-tech R and D Program (863 Program)

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.